CMG Pharmaceutical Co., Ltd. (058820.KQ)
KRW 1883.0
(-0.79%)
KRW 1883.0
(-0.79%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 3.03 Billion | 3.92 Billion | 1.28 Billion | 663.84 Million | 2.44 Billion | 796.57 Million |
| Net Income | 4.98 Billion | -308.23 Million | 652.98 Million | 355.76 Million | 2.64 Billion | 5.44 Billion |
| Depreciation & Amortization | 1.97 Billion | 1.81 Billion | 254.65 Million | 238.53 Million | 1.82 Billion | 1.65 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 42.94 Million | 18.92 Million | 176.39 Million | 82.62 Million | 380.05 Million | 297.55 Million |
| Change in working capital | -4.32 Billion | -8.34 Billion | -51.78 Million | 68.04 Million | -4.54 Billion | -3.2 Billion |
| Other non-cash items | 370.05 Million | 10.74 Billion | 249.82 Million | -81.12 Million | 2.14 Billion | -3.4 Billion |
| Investing Cash Flow | -21.78 Billion | -8.63 Billion | -522.04 Million | -432.71 Million | -61.1 Billion | 7.88 Billion |
| Investments in PPE | -9.55 Billion | -6.65 Billion | -442.47 Million | -373.35 Million | -7.07 Billion | -2.28 Billion |
| Acquisitions | -2.41 Billion | - | - | - | - | - |
| Investment purchases | -112.62 Billion | - | - | - | - | - |
| Sales/Maturities of investments | 95.79 Billion | - | - | - | - | - |
| Other Investing Activities | -9.8 Billion | -1.97 Billion | -79.56 Million | -59.36 Million | -54.02 Billion | 10.17 Billion |
| Financing Cash Flow | 16.25 Billion | 4.46 Billion | -548.6 Million | -104.85 Million | 63.08 Billion | - |
| Debt repayment | -21.5 Billion | -6 Billion | - | - | -98.29 Million | - |
| Dividends payments | -29.28 Million | - | - | - | - | - |
| Common Stock Repurchased | - | - | -546.33 Million | -102.95 Million | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -652.10 | - | -2.27 Million | -1.89 Million | 63.17 Billion | - |
| Accounts receivables | -2.21 Billion | -1.16 Billion | -1.68 Million | 3.01 Million | -2.75 Billion | -2.28 Billion |
| Accounts payables | -2.04 Billion | - | - | - | - | - |
| Inventory | -384.14 Million | -7.03 Billion | -6.39 Million | -394 Thousand | -813.17 Million | -1.03 Billion |
| Other working capital | -1.73 Billion | -151.39 Million | -43.7 Million | 65.42 Million | -977.35 Million | 113.36 Million |
| Cash at beginning of period | 3.53 Billion | - | 635.83 Million | 508.48 Million | 12.09 Billion | 3.56 Billion |
| Cash at end of period | 958.97 Million | 3.53 Billion | 846.23 Million | 635.83 Million | 16.07 Billion | 12.09 Billion |
| Capital Expenditure | -9.55 Billion | -6.65 Billion | -442.47 Million | -373.35 Million | -7.07 Billion | -2.28 Billion |
| Effect of forex changes on cash | 2.36 Million | -749.75 Thousand | -1.03 Million | 1.07 Million | 378.24 Thousand | -513.51 Thousand |
| Net cash flow / Change in cash | -2.57 Billion | 3.53 Billion | 210.39 Million | 127.35 Million | 3.97 Billion | 8.53 Billion |
| Free Cash Flow | -6.51 Billion | -2.73 Billion | 839.6 Million | 290.49 Million | -4.63 Billion | -1.49 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 5.98 Billion | 1.66 Billion | -2.04 Billion | 6.45 Billion | 2 Billion | 2.8 Billion |
| Depreciation & Amortization | 910.84 Million | 515.03 Million | 543.66 Million | 2.55 Billion | 478.8 Million | 470.21 Million |
| Deferred income taxes | - | - | - | 6.16 Billion | - | - |
| Stock-based compensation | 8.07 Million | 12.02 Million | 12.23 Million | 60.29 Million | 11.1 Million | 12.1 Million |
| Change in working capital | -4.42 Billion | 323.08 Million | -1.11 Billion | -7.65 Billion | 395.26 Million | -2.01 Billion |
| Other non-cash items | -402.91 Million | -1.04 Billion | 5.48 Billion | -3.67 Billion | -1.58 Billion | -106.6 Million |
| Investing Cash Flow | -8 Billion | -674.68 Million | -6.08 Billion | -28.22 Billion | -3.33 Billion | -12.63 Billion |
| Investments in PPE | -15.13 Billion | -12.58 Billion | -4.82 Billion | -15.24 Billion | -2.28 Billion | 584.07 Million |
| Acquisitions | - | - | -2.41 Billion | -3.12 Billion | - | - |
| Investment purchases | -44.74 Billion | - | - | -112.62 Billion | - | - |
| Sales/Maturities of investments | 40.49 Billion | - | - | 95.79 Billion | - | - |
| Other Investing Activities | -516.13 Million | 11.9 Billion | 1.15 Billion | 6.98 Billion | -1.04 Billion | -13.22 Billion |
| Financing Cash Flow | 8.39 Billion | 686.06 Million | -74.41 Million | 21.09 Billion | -75.43 Million | 1.81 Billion |
| Debt repayment | -8.1 Billion | -1 Billion | - | -21.5 Billion | - | -2.52 Billion |
| Dividends payments | - | - | - | -22.59 Million | - | -22.22 Million |
| Common Stock Repurchased | - | - | - | -661.49 Million | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 374.32 Million | -180.40 | -74.41 Million | 21.09 Billion | -75.43 Million | 1.83 Billion |
| Accounts receivables | -2.56 Billion | 57.54 Million | 991.11 Million | -11.21 Million | -864.46 Million | -1.44 Billion |
| Accounts payables | 103.39 Million | - | - | 11.21 Million | - | - |
| Inventory | 33 Million | -816.16 Million | -529.49 Million | -497.72 Million | 1.29 Billion | -69.24 Million |
| Other working capital | -1.99 Billion | 1.08 Billion | -1.57 Billion | -7.16 Billion | -35.37 Million | -498.8 Million |
| Cash at beginning of period | 3.24 Billion | 958.97 Million | 4.37 Billion | 4.45 Billion | 6.33 Billion | 16.11 Billion |
| Cash at end of period | 2.62 Billion | 2.4 Billion | 958.97 Million | 1.24 Billion | 4.37 Billion | 6.33 Billion |
| Capital Expenditure | -15.13 Billion | -12.58 Billion | -4.82 Billion | -15.24 Billion | -2.28 Billion | 584.07 Million |
| Effect of forex changes on cash | -4.86 Million | 3.7 Million | -327.52 Million | 3.07 Million | 296.78 Million | 15.44 Million |
| Net cash flow / Change in cash | -615.85 Million | 1.45 Billion | -3.41 Billion | -3.21 Billion | -1.96 Billion | -9.77 Billion |
| Free Cash Flow | -16.14 Billion | -11.11 Billion | -1.94 Billion | -11.33 Billion | -977.34 Million | 1.75 Billion |
600785
5280
1361
LLAP
8081
002910